Capecitabine in Low Risk Triple Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults
- Status
- RECRUITING
- Phase
- PHASE2
Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
- Status
- RECRUITING
- Phase
- PHASE2
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC
- Status
- RECRUITING
- Phase
- N/A
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
- Status
- RECRUITING
- Phase
- PHASE2
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
- Status
- RECRUITING
- Phase
- PHASE2
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1